title: Pushing the pedal to the metal: should we accelerate infliximab therapy for patients with severe ulcerative colitis?
authors.affiliation: Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina.
authors.forename: Hans H
authors.initials: HH
authors.lastname: Herfarth
authors.affiliation: Division of Gastroenterology and Hepatology, University of Zurich, Zurich, Switzerland.
authors.forename: Gerhard
authors.initials: G
authors.lastname: Rogler
authors.affiliation: Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan.
authors.forename: Peter D R
authors.initials: PD
authors.lastname: Higgins
mesh_terms: D000818:Animals; D003082:Colectomy; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D060828:Induction Chemotherapy / Q000379:methods*; D000069285:Infliximab / Q000008:administration & dosage*; D008297:Male
chemical_list: D007155:Immunologic Factors; D000069285:Infliximab